Literature DB >> 9573248

Role of interleukin-12 in primary influenza virus infection.

J M Monteiro1, C Harvey, G Trinchieri.   

Abstract

The effect of endogenous interleukin-12 (IL-12) on the influenza virus immune response in BALB/c mice was evaluated. Following primary influenza virus infection, IL-12 mRNA and protein are detected in the lung, with live virus being required for cytokine induction. Endogenous IL-12 contributes to early NK cell-dependent gamma interferon (IFN-gamma) production (days 3 and 5) but not late T-cell-dependent IFN-gamma secretion (day 7). IL-12 contributes to the inhibition of early virus replication but is not required for virus clearance. IL-12 also modestly contributes to the activation of cytotoxic T lymphocytes. Thus, in this model of experimental influenza virus infection, endogenous IL-12 contributes primarily to the early development and activation of the innate immune response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573248      PMCID: PMC110027          DOI: 10.1128/JVI.72.6.4825-4831.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells.

Authors:  M Fellous; U Nir; D Wallach; G Merlin; M Rubinstein; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

2.  Passive transfer of local immunity to influenza virus infection by IgA antibody.

Authors:  K B Renegar; P A Small
Journal:  J Immunol       Date:  1991-03-15       Impact factor: 5.422

3.  Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination.

Authors:  A Wille; A Gessner; H Lother; F Lehmann-Grube
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

4.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

5.  In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection.

Authors:  J Stein-Streilein; J Guffee
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

6.  Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. Implications in immunopathogenesis and protection.

Authors:  S Kanangat; J Thomas; S Gangappa; J S Babu; B T Rouse
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

7.  Influenza-specific antibody-secreting cells and B cell memory in the murine lung after immunization with wild-type, cold-adapted variant and inactivated influenza viruses.

Authors:  P D Jones; G L Ada
Journal:  Vaccine       Date:  1987-09       Impact factor: 3.641

8.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

9.  Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.

Authors:  M J Robertson; R J Soiffer; S F Wolf; T J Manley; C Donahue; D Young; S H Herrmann; J Ritz
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

10.  Response to influenza infection in mice with a targeted disruption in the interferon gamma gene.

Authors:  M B Graham; D K Dalton; D Giltinan; V L Braciale; T A Stewart; T J Braciale
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  53 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  Dendritic cell activation by recombinant hemagglutinin proteins of H1N1 and H5N1 influenza A viruses.

Authors:  Wen-Chun Liu; Shih-Chang Lin; Yen-Ling Yu; Ching-Liang Chu; Suh-Chin Wu
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

3.  Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice.

Authors:  T Hori; J Kiyoshima; K Shida; H Yasui
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

4.  TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway.

Authors:  Jason Z Oh; Jonathan S Kurche; Matthew A Burchill; Ross M Kedl
Journal:  Blood       Date:  2011-08-02       Impact factor: 22.113

Review 5.  Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals.

Authors:  Rosa Barreira da Silva; Christian Münz
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

6.  Memory CD4+ T cells induce innate responses independently of pathogen.

Authors:  Tara M Strutt; K Kai McKinstry; John P Dibble; Caylin Winchell; Yi Kuang; Jonathan D Curtis; Gail Huston; Richard W Dutton; Susan L Swain
Journal:  Nat Med       Date:  2010-05-02       Impact factor: 53.440

7.  Influenza virus vaccination induces interleukin-12/23 receptor beta 1 (IL-12/23R beta 1)-independent production of gamma interferon (IFN-gamma) and humoral immunity in patients with genetic deficiencies in IL-12/23R beta 1 or IFN-gamma receptor I.

Authors:  Tjitske de Boer; Jaap T van Dissel; Taco W J Kuijpers; Guus F Rimmelzwaan; Frank P Kroon; Tom H M Ottenhoff
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

8.  Spread of infection and lymphocyte depletion in mice depends on polymerase of influenza virus.

Authors:  Gülsah Gabriel; Karin Klingel; Oliver Planz; Katja Bier; Astrid Herwig; Martina Sauter; Hans-Dieter Klenk
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

9.  Interleukin-12 and host defense against murine Pneumocystis pneumonia.

Authors:  Sanbao Ruan; Laura McKinley; Mingquan Zheng; Xiaowen Rudner; Alain D'Souza; Jay K Kolls; Judd E Shellito
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

10.  Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine.

Authors:  Ioanna Skountzou; Maria del Pilar Martin; Baozhong Wang; Ling Ye; Dimitrios Koutsonanos; Will Weldon; Joshy Jacob; Richard W Compans
Journal:  Vaccine       Date:  2009-08-03       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.